Dudediligence.

Recursion Pharmaceuticals, Inc

RXRXNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Filings

Newest first

The annual , the quarterly and the filed between them when something material happens.

  1. Sep 218-KMaterial agreement1.01
  2. Aug 713GPassive stake of 5% or more (13G)
  3. Aug 510-QQuarterly report
  4. Aug 58-KResults of operations and Regulation FD disclosure2.027.019.01
  5. Jul 3113GPassive stake of 5% or more (13G), filed by Vanguard Portfolio Management
  6. Jul 3113GPassive stake of 5% or more (13G), filed by Vanguard Capital Management
  7. Jun 188-KShareholder vote5.07
  8. May 610-QQuarterly report
  9. May 68-KResults of operations and Regulation FD disclosure2.027.019.01
  10. Apr 308-KOfficer or director change and Regulation FD disclosure5.027.019.01
  11. Mar 258-KOfficer or director change and Regulation FD disclosure5.027.019.01
  12. Feb 25424B5Prospectus for an offering
  13. Feb 2510-KAnnual report
  14. Feb 258-KResults of operations and Regulation FD disclosure2.027.019.01
  15. Jan 128-KRegulation FD disclosure7.019.01
  16. Dec 8, 20258-KOther events8.019.01
  17. Nov 26, 20258-KOther events8.019.01
  18. Nov 5, 202510-QQuarterly report
  19. Nov 5, 20258-KResults of operations and officer or director change2.025.027.019.01
  20. Oct 29, 20258-KOther events8.01
  21. Aug 29, 20258-K/AUnregistered sale of shares and other events (amended)3.028.019.01